Glucose variability and complications

被引：20

作者：

Bolli, Geremia B. ^{[1
]}

机构：

[1] Univ Perugia, Dept Internal Med, Sect Internal Med Endocrinol & Metab, I-06126 Perugia, Italy

来源：

DIABETES CARE | 2006年 / 29卷 / 07期

关键词：

D O I：

10.2337/dc06-0716

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1707 / 1709

页数：3

共 18 条

[1]

[Anonymous], 1995, DIABETES, V44, P968

[2] Postprandial hyperglycemia and diabetes complications - Is it time to treat? [J].

Ceriello, A .

DIABETES, 2005, 54 (01) :1-7

[3]

Childs BP, 2005, DIABETES CARE, V28, P1245

[4] Insulin therapy and hypoglycaemia: the size of the problem [J].

Fanelli, CG ;

Porcellati, F ;

Pampanelli, S ;

Bolli, GB .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2004, 20 :S32-S42

[5] Should minimal blood glucose variability become the gold standard of glycemic control? [J].

Hirsch, IB ;

Brownlee, M .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (03) :178-181

[6] Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial [J].

Hoogma, RPLM ;

Hammond, PJ ;

Gomis, R ;

Kerr, D ;

Bruttomesso, D ;

Bouter, KP ;

Wiefels, KJ ;

de la Calle, H ;

Schweitzer, DH ;

Pfohl, M ;

Torlone, E ;

Krinelke, LG ;

Bolli, GB .

DIABETIC MEDICINE, 2006, 23 (02) :141-147

[7] The effect of glucose variability on the risk of microvascular complications in type 1 diabetes [J].

Kilpatrick, Eric S. ;

Rigby, Alan S. ;

Atkin, Stephen L. .

DIABETES CARE, 2006, 29 (07) :1486-1490

[8] Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime [J].

Lalli, C ;

Ciofetta, M ;

del Sindaco, P ;

Torlone, E ;

Pampanelli, S ;

Compagnucci, P ;

Cartechini, MG ;

Bartocci, L ;

Brunetti, P ;

Bolli, GB .

DIABETES CARE, 1999, 22 (03) :468-477

[9] Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes [J].

Monnier, L ;

Mas, E ;

Ginet, C ;

Michel, F ;

Villon, L ;

Cristol, JP ;

Colette, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1681-1687

[10] Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients - The Verona Diabetes Study [J].

Muggeo, M ;

Bonadonna, RC ;

Zoppini, G ;

Moghetti, P ;

Bonora, E ;

Verlato, G ;

Brun, E .

DIABETES CARE, 2000, 23 (01) :45-50

← 1 2 →